Just eight days after signing a U.S. House Republican letter supporting a “robust 340B rebate model pilot,” a Mississippi congressman [...] …
Blog Posts
Exclusive
Novo Nordisk Says it Won’t Require Tennessee Providers to Report Claims Data Following AG Warning
A major drugmaker recently told a Tennessee official that it will not require state providers to submit 340B claims data [...] …
Please Login or Become a Paid Subscriber to View this Content
SPONSORED CONTENT
Covered entities participating in the 340B program continue to operate in an environment of increasing complexity and scrutiny. As regulatory expectations evolve, one area that has emerged as a critical point of vulnerability is referral documentation. While
…
A Brussels-based drugmaker recently became the seventh manufacturer to announce an expansion of its 340B claims data requirements to in-house pharmacy use, while a Chicago-based pharmaceutical giant updated its contract pharmacy restrictions to exempt Washington state covered entities.
UCB informed
…
Multiple 340B providers have recently received letters from Eli Lilly warning they could lose access to 340B pricing unless they [...] …
Please Login or Become a Paid Subscriber to View this Content
A New Orleans federal appeals court recently denied a major pharmaceutical manufacturer’s request to reconsider a ruling in favor of [...] …
Please Login or Become a Paid Subscriber to View this Content
WSJ Editorial Board Op-Ed Points to North Dakota Judge’s Contract Pharmacy Ruling, Calls 340B ‘Scam’
A major newspaper’s editorial board recently highlighted a federal judge’s ruling against North Dakota’s contract pharmacy access law to denounce [...] …
Please Login or Become a Paid Subscriber to View this Content
Louisiana Attorney General Liz Murrill (R) recently told a national legal news service that her office is preparing enforcement actions [...] …
Please Login or Become a Paid Subscriber to View this Content
A Louisiana cancer center leader—who serves on the board of a private practice oncologist trade group that’s corporate partners largely [...] …
Please Login or Become a Paid Subscriber to View this Content
SPONSORED CONTENT
In fiscal year 2025, the Health Resources and Services Administration (HRSA) audited 115 covered entities — and 49% received adverse findings. In other words, nearly one in two programs had a 340B compliance issue last year.
While this is an improvement
…